Objectives: The purpose of this study was to develop and establish reliability and validity of a virtual performance measure (VPM) score that encompassed 10 videos in patients with osteoarthritis of the knee joint. Patients' experience and satisfaction were documented.
Design: Forty videos were chosen for 10 functional tasks, with four videos showing increasing difficulty for each task. Patients were requested to choose the video that best reflected their own situation. Clinical and radiological findings and self-report and performance measures were completed.
Results: Data of 100 patients, 70 (70%) females, mean age: 65 ± 9 were examined. The Cronbach's alpha coefficient that examined internal consistency of the VPM score was 0.92. The intraclass correlation value of 0.82 was obtained for test-retest reliability. Factor analysis showed three distinct domains. There was moderate correlations between the VPM score and the self-report and actual performance measures ranging from r = 0.46 to 0.66. The VPM summated score of 10 activities was able to differentiate between candidates and non-candidates for knee arthroplasty, with the area under the curve value of 0.90 indicating excellent predictive validity. The overall patient experience and satisfaction was positive with 67% of participants feeling that virtual care could have an impact on minimizing physical presence in the clinic or hospital.
Conclusions: The VPM is a reliable and valid outcome measure in patients with osteoarthritis of the knee joint. This digital tool has the potential to transform osteoarthritis care by providing a valid remote measurement of real-life functional limitations and reduce the burden of time consuming in-person tests.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565872 | PMC |
| http://dx.doi.org/10.1016/j.ocarto.2023.100410 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Characteristics of Charcot-Marie-Tooth Disease Type 4J.
Neurology
September 2024
From the Department of Neurology (R.S., V.P.-M.), Massachusetts General Hospital, Harvard Medical School, Boston; Centre for Neuromuscular Diseases (J.M.M., M.M.R.), Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom; Department of Neurology (D.T.), and Department of Radiology (P.A.D.), University of Iowa Health Care, Carver College of Medicine, Iowa City; Michigan Neuroscience Institute (B.A.M.), University of Michigan, Ann Arbor; Unit of Medical Genetics and Neurogenetics (D.P.), Department of Diagnostics and Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; Department of Neurology (D.N.H.), University of Rochester, NY; Department of Neurology (J.L.), Houston Methodist Research Institute; Neurology & Neuromuscular Care Center/Neurology Rare Disease Center (D.C.), Denton, TX; and Department of Molecular Physiology and Biophysics (M.E.S.), University of Iowa Health Care, Carver College of Medicine, Iowa City.
Background And Objectives: Charcot-Marie-Tooth disease type 4J (CMT4J) is caused by autosomal recessive variants in the () gene. Recent preclinical work has demonstrated the feasibility of adeno-associated virus serotype 9-FIG4 gene therapy. This study aimed to further characterize the CMT4J phenotype and evaluate feasibility of validated CMT-related outcome measures for future clinical trials.
View Article and Find Full Text PDFBackground: The combined use of topical calcipotriol/betamethasone dipropionate (Cal/BDP) is commonly used and demonstrated to be effective for the management of psoriasis and is shown to confer local anti-inflammatory and immunoregulatory effects. The use of the two agents in combination is synergistic. Despite the demonstrated efficacy of topically applied combination Cal/BDP, successful management of a chronic, relapsing inflammatory skin disease such as psoriasis in the real-world setting may be hindered if patients do not adhere to the dosing or frequency of application recommendations from their prescriber.
View Article and Find Full Text PDFVirtual performance measure in osteoarthritis: An innovative transformation of patient care.
Osteoarthr Cartil Open
December 2023
Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.
Objectives: The purpose of this study was to develop and establish reliability and validity of a virtual performance measure (VPM) score that encompassed 10 videos in patients with osteoarthritis of the knee joint. Patients' experience and satisfaction were documented.
Design: Forty videos were chosen for 10 functional tasks, with four videos showing increasing difficulty for each task.
Vesicoprostatic muscle reconstruction: a step further for immediate and early urinary continence.
World J Urol
June 2023
Department of Urology, The Third Medical Centre, Chinese PLA General Hospital, Beijing, People's Republic of China.
Objectives: The vesicoprostatic muscle (VPM) is a longitudinal smooth muscle that originates from the trigone of the bladder or the opening of the ureter and is involved in urination as part of the detrusor apron. We explored the effect of VPM reconstruction on immediate and early recovery of urinary continence in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP).
Patients And Methods: A total of 523 patients with localized prostate cancer were enrolled from June 2018 to June 2020.
Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis.
Clin Transl Gastroenterol
June 2023
Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Article Synopsis
- Researchers hypothesized that FGF-21 levels would be elevated in patients with alcohol-associated hepatitis (AH) and could serve as a new, reliable biomarker to differentiate between severe AH and decompensated alcohol-associated cirrhosis (AC).
- The study included a discovery cohort of 88 subjects and a validation cohort of 37 patients, where serum FGF-21 levels were measured and analyzed using statistical models for comparison.
- Results showed significant elevation of FGF-21 in severe AH patients compared to AC, suggesting that FGF-21 could act as a useful biomarker for clinicians in managing alcohol-associated liver diseases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!